4-Bromo-2-methylbenzoic acid → (4-Bromo-2-methylphenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone
反応式
[CH3:1][C:2]1[C:3]([N:9]2[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]2)=[N:4][CH:5]=[C:6]([CH3:8])[CH:7]=1.[Br:15][C:16]1[CH:24]=[CH:23][C:19]([C:20](O)=[O:21])=[C:18]([CH3:25])[CH:17]=1.O.[Cl-].COC1N=C(OC)N=C([N+]2(C)CCOCC2)N=1>C(Cl)(Cl)Cl.CO>[Br:15][C:16]1[CH:24]=[CH:23][C:19]([C:20]([N:12]2[CH2:11][CH2:10][N:9]([C:3]3[C:2]([CH3:1])=[CH:7][C:6]([CH3:8])=[CH:5][N:4]=3)[CH2:14][CH2:13]2)=[O:21])=[C:18]([CH3:25])[CH:17]=1参加物
6
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
1-(3,5-Dimethylpyridin-2-yl)piperazine (3.8 g) described in Preparation Example 79 and 4-bromo-2-methylbenzoic acid (4.3 g) were dissolved in a solution of chloroform (30 mL) and methanol (30 mL), 4-(4,6-dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrate (DMT-MM) (8.8 g) was added, and the mixture was stirred at room temperature overnight. The solvent was evaporated from the reaction mixture, ethyl acetate was added, and the insoluble material was collected by filtration. The solvent was evaporated from the obtained filtrate, and the residue was purified by column chromatography (hexane:ethyl acetate) to give the title compound (7 g).
後処理
- additionwas added
- customThe solvent was evaporated from the reaction mixture, ethyl acetate
- additionwas added
- filtrationthe insoluble material was collected by filtration
- customThe solvent was evaporated from the obtained filtrate
- customthe residue was purified by column chromatography (hexane:ethyl acetate)
出典と根拠
- ORDレコード
- ord-0e0613eb7f1b41298e739ce964ce5c89
- 出典データセット
- uspto-grants-2014_08
- 特許番号
- US08816079B2
反応ノート
読み込み中…